CLPT
Clearpoint Neuro Inc
10.90$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -288.7% | -163.4% | -147.0% | -197.9% | -201.1% | -188.0% | -101.2% | -81.2% | -63.0% | -25.4% | -60.9% | -77.9% | -78.7% | -57.3% | -28.5% | -64.7% | |
| 10.0% | 9.3% | 8.2% | 10.8% | 10.5% | 4.6% | 2.7% | 1.6% | 1.5% | 2.2% | 4.3% | 4.2% | 3.8% | 6.3% | 6.1% | 2.7% | |
| 9.2% | 25.9% | 40.2% | 37.1% | 24.4% | 36.6% | 16.7% | 16.9% | 16.7% | 7.1% | 8.5% | 12.7% | 20.1% | 25.4% | 22.0% | 22.1% | |
| – | – | – | – | – | – | 17.3% | 23.4% | 16.9% | 7.1% | 1.5% | 16.0% | 19.5% | – | – | – | |
| -9.2% | -16.6% | -125.8% | -52.2% | 34.4% | -25.3% | 11.7% | -14.8% | -5.2% | 8.1% | -20.8% | -10.3% | -20.9% | -5.9% | 4.5% | -26.5% | |
| 2.3% | 0.7% | 2.5% | 4.4% | 1.3% | 1.7% | 1.8% | 0.4% | 0.9% | 1.4% | 3.8% | 1.0% | 1.2% | 3.0% | 0.9% | 1.4% | |
| -2.3% | -0.7% | -2.5% | -4.4% | -1.3% | -1.7% | -1.8% | -0.4% | -0.9% | -1.4% | -3.8% | -1.0% | -52.2% | 37.4% | -0.9% | 1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | 2.7% | 1.0% | – | – | – | |
| – | – | – | – | – | 106.2% | -0.1% | 0.0% | 6.9% | 69.7% | 192.0% | -3.7% | -1.6% | -0.9% | 1.4% | – | |
| – | – | – | – | – | – | -34.8% | -27.1% | -27.2% | -19.1% | 173.9% | 0.0% | – | 0.0% | -31.9% | 130.1% | |
| 253.9% | 126.6% | 178.6% | 250.6% | 361.4% | 106.2% | 66.6% | 162.5% | -20.3% | 50.0% | 176.9% | 287.6% | 2.0% | 1.2% | 19.7% | 135.7% | |
| -37.2% | -37.5% | 29.2% | 48.2% | 158.9% | -83.5% | -36.4% | 81.0% | -84.2% | 23.1% | 112.3% | 208.7% | -128.9% | -18.7% | -9.7% | 72.7% | |
| -291.0% | -164.1% | -149.5% | -202.3% | -202.5% | -189.7% | -103.0% | -81.6% | -63.8% | -26.8% | -64.6% | -78.9% | -79.9% | -60.3% | -29.4% | -66.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.